Raffella Giuffrida

10PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 27, 2025
Single-Vesicle Molecular Profiling by dSTORM Imaging in a Liquid Biopsy Assay Predicts Early Relapse in Colorectal Cancer.

Gabriele Raciti, Giulia Cavallaro, Raffaella Giuffrida

|Aug 09, 2024
A Novel Liquid Biopsy Method Based on Specific Combinations of Vesicular Markers Allows Us to Discriminate Prostate Cancer from Hyperplasia.

Emanuele Martorana, Gabriele Raciti, Raffaella Giuffrida

|Mar 28, 2024
Correction: Casili et al. Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC). <i>Cancers</i> 2023, <i>15</i>, 2796.

Giovanna Casili, Sarah Adriana Scuderi, Marika Lanza

|Jun 22, 2023
Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC).

Giovanna Casili, Sarah Adriana Scuderi, Marika Lanza

|Apr 13, 2023
Role of Basic Fibroblast Growth Factor in Cancer: Biological Activity, Targeted Therapies, and Prognostic Value.

Alessio Ardizzone, Valentina Bova, Giovanna Casili

|Dec 23, 2022
The Pivotal Role of Protein Phosphatase 2A (PP2A) in Brain Tumors.

Laura Cucinotta, Alessia Filippone, Giovanna Casili

Pageof 2

Frequent Collaborators

6 joint publications

Salvatore Cuzzocrea

6 joint publications

Emanuela Esposito

5 joint publications

Cristina Colarossi

4 joint publications

Stefano Forte